J Glob Health. 2022 May 23;12:05020. doi: 10.7189/jogh.12.05020.
The devastating health and economic impact of the COVID-19 pandemic led to a global response in the development of effective vaccines to fight the disease in an extraordinarily short time. Both the development and the production of these vaccines opened a path of hope, but the inequality in vaccine distribution raises great concerns about the possibility of effectively eradicating the virus.
It is particularly important to analyse the extent to which vaccines are equally distributed and investigate the possible effects of vaccine inequalities as well as its major drivers. For this purpose, this paper investigates the extent of equitable vaccine distribution using some well-known inequality measures and disentangles the main drivers of the share of vaccination. In addition, the paper analyses the relationship between the vaccination rate, the GDP growth, and the incidence of the coronavirus disease, with the aim of providing empirical evidence on existing relationships worldwide.
Our findings show that the situation is more challenging in less developed countries, especially African countries, due to weak health systems and low rates of vaccination. Moreover, we find a positive relationship between the share of vaccinated individuals and GDP. Consequently, the poorest, least developed countries with a lower rate of vaccine uptake will experience lower GDP growth.
Vaccines and the vaccination process reveal the existing inequalities between countries and how they, in turn, impact the well-being of their citizens. People who live in less developed countries have a lower probability of being vaccinated, which translates into a greater probability of dying from COVID. Countries are seeing their economic future compromised by low vaccination levels, given the positive and significant relationship between the vaccination rate and GDP growth. In short, while some countries are trying to get back to some sort of normality, even with some pandemic protocols, the situation in less developed countries is more challenging due to weak health systems and low rates of vaccination. Consequently, the poorest, least developed countries with a lower rate of vaccine penetration will experience lower GDP growth, and the pandemic will have a greater effect on their economy due to low vaccination rates.
COVID-19 大流行对健康和经济造成了毁灭性影响,促使全球采取行动,在极短时间内开发出有效疫苗来对抗这种疾病。这些疫苗的开发和生产都为人们带来了希望,但疫苗分配的不平等引起了人们对有效消灭病毒的可能性的极大关注。
分析疫苗分配是否平等,研究疫苗不平等及其主要驱动因素的可能影响,这一点尤为重要。为此,本文使用一些著名的不平等指标来评估疫苗公平分配的程度,并分解接种份额的主要驱动因素。此外,本文还分析了疫苗接种率、国内生产总值增长和冠状病毒病发病率之间的关系,目的是提供全球现有关系的经验证据。
我们的研究结果表明,由于卫生系统薄弱和接种率低,较不发达国家,特别是非洲国家的情况更为严峻。此外,我们发现接种人群比例与 GDP 呈正相关。因此,疫苗接种率较低的最贫穷、最不发达国家的 GDP 增长将会更低。
疫苗和接种过程揭示了国家之间存在的不平等,以及这些不平等如何反过来影响其公民的福祉。生活在较不发达国家的人接种疫苗的可能性较低,因此死于 COVID 的可能性更大。鉴于疫苗接种率与 GDP 增长之间存在正相关且显著的关系,接种率较低的国家经济前景受到影响。简而言之,虽然一些国家正在努力恢复某种常态,甚至采用一些大流行协议,但由于卫生系统薄弱和接种率低,较不发达国家的情况更为严峻。因此,疫苗普及率较低的最贫穷、最不发达国家的 GDP 增长将会更低,而且由于疫苗接种率低,大流行对其经济的影响将会更大。